RGC,Regencell Bioscience Holdings Limited | Healthcare

Healthcare

RGC

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Regencell Bioscience Holdings LimitedRGC

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.

It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder, as well as infectious diseases.

The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Latest News >

Oil prices set for steepest weekly drop in 3 months

May 2, 2024

(Reuters) -Oil prices edged up on Friday on the prospect of OPEC+ continuing output cuts, but the crude benchmarks were headed for the steepest weekly losses in three months on demand uncertainty and easing tensions in the Middle East reducing supply risks. Brent crude futures for July rose 24 cents to $83.91 a barrel by 0514 GMT. U.S. West Texas...

GLOBAL MARKETS-Asian stocks surge; yen extends gains to cap wild week

May 2, 2024

(Updates at 0510 GMT) By Ankur Banerjee SINGAPORE, May 3 (Reuters) - Asian stocks surged to their highest in 15 months on Friday led by tech and Hong Kong stocks, while the yen put more distance from recent 34-year lows to cap a tumultuous week that saw suspected intervention from Japanese authorities. With markets in Japan and mainland China closed...

SVB Financial to sell VC business SVB Capital

May 2, 2024

May 2 (Reuters) - Collapsed U.S. lender SVB Financial Group ( SIVBQ ) said on Thursday that an entity affiliated with Pinegrove Capital Partners will acquire its venture capital business, SVB Capital. A newly-created entity, backed by permanent capital from Brookfield and Sequoia Heritage, will buy SVB Capital for a combination of cash and other economic considerations, SVB Financial (...

Research Alert: CFRA Maintains Hold Opinion On Adss Of Shell Plc

May 2, 2024

01:17 AM EDT, 05/03/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our TP for Shell to $71 ($66), reflecting a P/NAV of 1.2x, broadly in line with peer average of 1.2x. Q1 2024 adjusted earnings of $7.7 billion (-20%...